CardioVascular Research Foundation, Korea
105
17
23
51
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 70/100
26.7%
28 terminated/withdrawn out of 105 trials
64.6%
-21.9% vs industry average
40%
42 trials in Phase 3/4
0%
0 of 51 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (105)
Effect of FFR Guided Percutaneous Coronary Intervention in Coronary Tandem Lesions
Role: collaborator
Evaluation of Effectiveness and Safety of Hybrid Coronary Revascularization
Role: collaborator
Observational Study for Left Main Disease Treatment
Role: collaborator
Study of the Natural History of FFR Guided Percutaneous Coronary Intervention
Role: collaborator
IRIS-Onyx Cohort in the IRIS-DES Registry
Role: collaborator
Evaluation of Effectiveness and Safety of Rotational Atherectomy in Routine Clinical Practice
Role: collaborator
Transpacific TAVR Registry
Role: collaborator
Evaluation of Effectiveness and Safety of Xience Skypoint Stents in Routine Clinical Practice
Role: collaborator
Asan Multivessel Registry
Role: collaborator
Evaluation of Effectiveness and Safety of XIENCE Sierra in Routine Clinical Practice
Role: collaborator
IRIS- DESyne X2 in the IRIS-DES Registry
Role: collaborator
Optical Coherence Tomography Versus Intravascular Ultrasound Guided Percutaneous Coronary Intervention
Role: collaborator
Prognosis of Coronary Stenosis Based on Intracoronary Imaging; A Multicenter, Prospective Observational Study
Role: collaborator
ASAN Medical Center Aortic Valve Replacement Registry
Role: collaborator
Asan Medical Center Myocardial Infarction Registry
Role: collaborator
Evaluation of Effectiveness and Safety of Aortic Valve Replacement in Routine Clinical Practice
Role: collaborator
Diabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Percutaneous Coronary Intervention or Coronary-Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease
Role: collaborator
Evaluation of Effectiveness and Safety of Synergy XD and Synergy Megatron™ Stent
Role: collaborator
IRIS Ultimaster Cohort in the IRIS-DES Registry
Role: collaborator
Drug-Eluting Balloon Registry in Routine Clinical Practice
Role: collaborator